MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα

Area of Science:

• Molecular Biology
• Cell Biology
• Metabolic Regulation

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression impacting lipid homeostasis.
• MiR-613 is a newly identified miRNA with an unknown function.
• Previous studies indicate miR-613 downregulates liver X receptor alpha (LXRα), a crucial factor in lipid metabolism.

Purpose of the Study:

• To investigate the effect of miR-613 on lipogenesis in HepG2 cells.
• To elucidate the molecular mechanism by which miR-613 influences lipid metabolism.

Main Methods:

• HepG2 cells were transfected with miR-613 mimic.
• Quantitative real-time PCR and Western blot analyzed gene and protein expression.
• Luciferase reporter assays confirmed direct binding of miR-613 to LXRα mRNA.
• Oil Red O staining assessed lipid droplet accumulation.

Main Results:

• MiR-613 significantly suppressed LXRα expression and its downstream lipogenic targets (SREBP-1c, FAS, ChREBP, ACC).
• Direct binding of miR-613 to the 3'-UTR of LXRα mRNA was confirmed.
• MiR-613 reduced lipid droplet accumulation in HepG2 cells.
• Restoring LXRα expression without the 3'-UTR partially rescued the effects of miR-613.

Conclusions:

• MiR-613 suppresses lipogenesis by directly targeting LXRα in HepG2 cells.
• MiR-613 represents a novel therapeutic target for regulating lipid homeostasis.